The goal of this paper is to share challenges, suggestions, and classes learned concerning the event and implementation of a Patient Safety Learning Laboratory (PSLL) project, an innovative and complex intervention comprised of a suite of Health Information Technology (HIT) instruments built-in with a newly applied Electronic Health Record (EHR) vendor system in the acute care setting at a large academic heart.
The PSLL Administrative Core engaged stakeholders and research personnel all through all phases of the project: downside evaluation, design, growth, implementation, and analysis. Implementation challenges and suggestions had been derived from direct observations and the collective expertise of PSLL research personnel.
The PSLL intervention was applied on 12 inpatient items through the 18-month research interval, doubtlessly impacting 12,628 patient admissions. Challenges to implementation included stakeholder engagement, project scope/complexity, know-how/governance, and workforce construction. Recommendations to deal with every of those challenges had been generated, some enacted through the trial, others as classes learned for future iterative refinements of the intervention and its implementation.Designing, implementing, and evaluating a suite of instruments built-in inside a vendor EHR to enhance patient safety has a number of challenges.
Keys to success embrace steady stakeholder engagement, involvement of methods and human elements engineers inside a multidisciplinary workforce, an iterative strategy to user-centered design, and a willingness to assume outdoors of present workflows and processes to vary well being system tradition round hostile occasion prevention.
Undergraduate nursing pupil perceptions of directed self-guidance in a learning laboratory: An instructional technique to boost confidence and office readiness.
A self-directed learning laboratory (SDL Lab) was established in which undergraduate nursing college students had been offered entry to skilled nurses in a simulated ward atmosphere to boost preparedness for medical follow. The intention of this research was to discover views of ultimate 12 months, undergraduate pupil nurses in regards to the SDL Lab and directed self-guidance, with specific concentrate on the affect on learning and preparedness for skilled follow.
The research was framed inside a qualitative descriptive strategy utilizing semi-structured, digitally recorded face-to-face interviews. The purposive pattern included undergraduate college students enrolled in their closing 12 months of a Bachelor of Nursing program, who had accessed the SDL Lab on no less than two events. Thematic evaluation was used.
Twelve college students participated. Three most important themes had been recognized: 1) A protected atmosphere that fosters efficient learning; 2) Directed self-guidance strengthens confidence and competence throughout office experiences; 3) Enhancing accessibility and realism will enhance learning. Reports of elevated confidence in performing nursing abilities was discovered in this research. Evaluation of the SDL Lab discovered that this different instructing technique was beneficial, and college students appreciated the protected learning atmosphere. Future analysis would possibly discover measurement of the impact of directed self-guidance in an SDL facility on competence and confidence.
Radiography Students’ Learning of Plain X-Ray Examinations in Simulation Laboratory Exercises: An Ethnographic Research.
In addition to classes and medical coaching, simulation-based learning has turn into extra ubiquitous in radiography college students’ learning. Plain examinations are in the core of radiography, and learning how college students be taught them in simulation is subsequently important when contemplating college students’ skilled growth. The objective of this research was to explain radiography college students’ learning to carry out plain X-ray examinations in simulation laboratory workouts.
The intention was to know how the scholars learned.The information had been gathered by observing and interviewing 17 radiography college students as they carried out laboratory workouts of plain X-ray examinations earlier than medical coaching. Learning was understood in line with social constructivism and was examined from the attitude of interpretive ethnography. Data had been analyzed utilizing the fixed comparative technique.In simulation laboratory workouts, radiography college students learned by model-based experimentation.

Learning consisted of imaging bone and chest examinations of a manikin, analysis of the pictures, and patient positioning and steering amongst college students. The learning technique was collaborative learning. Three learning outcomes had been discovered: simulation promoted theory-practice connection, simulation guided the scholars to observe directions, and simulation strengthened collaboration between college students. The elements supporting and impeding learning had been the identical: academic research earlier than the simulation and learning duties.
In addition, experimentation with out trainer’s supervision was an impeding issue for some college students.Simulation laboratory workouts with a manikin proved to be a helpful learning technique for radiography college students in learning to carry out plain X-ray examinations. The outcomes indicated the necessity to concentrate to simulation pedagogy and college students’ academic abilities.
Students’ perceptions of instructing elements that demotivate their learning in lectures and laboratory-based abilities follow.
The goal of this paper is to report college students’ perceptions of things that demotivated their learning in lectures and laboratory-based abilities follow settings.A complete of 23 college students had been recruited from the Bachelor of Nursing programs at three Japanese universities, utilizing purposive sampling. A semi-structured interview was performed with every participant between November 2017 and January 2018 to elicit their perceptions about which elements of the instructing context demotivated their engagement in learning.
The outcomes had been analyzed utilizing thematic evaluation.Three themes had been generated: a restrictive atmosphere, discouraging attitudes and discouraging instructing approaches.To forestall college students from experiencing demotivation, academics in the nursing school have to handle learning assets extra successfully, create a quiet and centered ambiance to permit college students to pay attention, and be keen about instructing.
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-Mu-48T |
DL Develop |
48T |
EUR 435 |
- Should the Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-Mu-96T |
DL Develop |
96T |
EUR 561 |
- Should the Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-Ra-48T |
DL Develop |
48T |
EUR 454 |
- Should the Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
DLR-Bcl2-Ra-96T |
DL Develop |
96T |
EUR 587 |
- Should the Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 516 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 716 |
Human B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 436 |
Human B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 601 |
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 447 |
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 618 |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 470 |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RDR-Bcl2-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 651 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 494 |
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 684 |
Human B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 418 |
Human B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 575 |
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 429 |
Mouse B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 591 |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 450 |
Rat B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
RD-Bcl2-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 622 |
BCL2, Apoptosis Regulator (BCL2) Antibody |
20-abx159344 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL2 antibody |
20R-2240 |
Fitzgerald |
50 ug |
EUR 281 |
Description: Rabbit polyclonal BCL2 antibody for detection of BCL2 in the research laboratory |
BCL2 antibody |
20R-2241 |
Fitzgerald |
50 ug |
EUR 281 |
Description: Rabbit polyclonal BCL2 antibody for detection of BCL2 in the research laboratory |
Bcl2 antibody |
20R-2960 |
Fitzgerald |
100 ul |
EUR 393 |
Description: Rabbit polyclonal Bcl2 antibody |
BCL2 antibody |
70R-11571 |
Fitzgerald |
100 ug |
EUR 451 |
Description: Rabbit polyclonal BCL2 antibody for detection of BCL2 in the research laboratory |
BCL2 antibody |
70R-13666 |
Fitzgerald |
100 ug |
EUR 365 |
Description: Affinity purified Rabbit polyclonal BCL2 antibody |
BCL2 antibody |
70R-15975 |
Fitzgerald |
50 ul |
EUR 435 |
Description: Rabbit polyclonal BCL2 antibody |
BCL2 Antibody |
35342-100ul |
SAB |
100ul |
EUR 390 |
BCL2 Antibody |
32012-100ul |
SAB |
100ul |
EUR 252 |
BCL2 antibody |
38472-100ul |
SAB |
100ul |
EUR 252 |
BCL2 antibody |
10R-2218 |
Fitzgerald |
100 ul |
EUR 403 |
Description: Mouse monoclonal BCL2 antibody for detection of BCL2 in the research laboratory |
BCL2 antibody |
10R-6619 |
Fitzgerald |
100 ug |
EUR 311 |
Description: Mouse monoclonal BCL2 antibody for detection of BCL2 in the research laboratory |
BCL2 antibody |
10R-7823 |
Fitzgerald |
100 ug |
EUR 305 |
Description: Mouse monoclonal BCL2 antibody |
BCL2 antibody |
10R-8029 |
Fitzgerald |
100 ug |
EUR 470 |
Description: Mouse monoclonal BCL2 antibody for detection of BCL2 in the research laboratory |
Bcl2 antibody |
10R-8482 |
Fitzgerald |
100 ul |
EUR 393 |
Description: Mouse monoclonal Bcl2 antibody |
Bcl2 antibody |
10R-8483 |
Fitzgerald |
100 ul |
EUR 393 |
Description: Mouse monoclonal Bcl2 antibody |
BCL2 Antibody |
1-CSB-PA832691 |
Cusabio |
|
|
- Form: Liquid
- Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
BCL2 Antibody |
1-CSB-PA000982 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human, Monkey. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
BCL2 Antibody |
1-CSB-PA000983 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000 |
BCL2 Antibody |
1-CSB-PA000984 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000 |
BCL2 Antibody |
1-CSB-PA002611GA01HU |
Cusabio |
|
|
- Form: Liquid
- Buffer: PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20℃, Avoid freeze / thaw cycles. Antigen Affinity Purified
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human, Mouse, Rat, Guinea pig. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
Bcl2 Antibody |
1-CSB-PA002611LA01MO |
Cusabio |
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified |
Description: A polyclonal antibody against Bcl2. Recognizes Bcl2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
BCL2 Antibody |
1-CSB-PA12959A0Rb |
Cusabio |
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified |
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:200-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
BCL2 Antibody |
1-CSB-PA597947 |
Cusabio |
|
|
- Form: Liquid
- Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:500-1:5000, WB:1:500-1:1000 |
BCL2 Antibody |
1-CSB-PA703826 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL2. Recognizes BCL2 from Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1:500-2000, ELISA:1:10000-20000 |
BCL2 antibody |
70R-35549 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Purified Rabbit polyclonal BCL2 antibody |
BCL2 antibody |
70R-36273 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal BCL2 antibody |
BCL2 antibody |
70R-37499 |
Fitzgerald |
100 ug |
EUR 273 |
Description: Rabbit Polyclonal BCL2 antibody |
BCL2 antibody |
70R-37500 |
Fitzgerald |
100 ug |
EUR 273 |
Description: Rabbit Polyclonal BCL2 antibody |
BCL2 antibody |
70R-49413 |
Fitzgerald |
100 ul |
EUR 287 |
Description: Purified Polyclonal BCL2 antibody |
BCL2 antibody |
70R-49414 |
Fitzgerald |
100 ul |
EUR 244 |
Description: Purified Polyclonal BCL2 antibody |
BCL2 antibody |
70R-51463 |
Fitzgerald |
100 ul |
EUR 287 |
Description: Purified Polyclonal BCL2 antibody |
BCL2 antibody |
70R-33373 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal BCL2 antibody |
BCL2 Antibody |
20-abx242957 |
Abbexa |
|
|
- Shipped within 1-2 weeks.
|
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNUM1023-50 |
Biotium |
50uL |
EUR 395 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), 1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNUB1023-100 |
Biotium |
100uL |
EUR 209 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Concentration: 0.2mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNUB1023-500 |
Biotium |
500uL |
EUR 458 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Concentration: 0.2mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC551023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF555 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC551023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF555 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC611023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF660R conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC611023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF660R conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC471023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF647 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC471023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF647 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC051023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF405M conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC051023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF405M conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC401023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF640R conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC401023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF640R conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC431023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF543 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC431023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF543 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC041023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF405S conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC041023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF405S conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC801023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF680 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC801023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF680 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCP1023-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), PerCP conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCR1023-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), RPE conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCA1023-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), APC conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCAP1023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCAP1023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCB1023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Biotin conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCB1023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Biotin conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCH1023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNCH1023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC881023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF488A conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC881023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF488A conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC941023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF594 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC941023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF594 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC681023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF568 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC681023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF568 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC701023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF770 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC701023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF770 conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC811023-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF680R conjugate, Concentration: 0.1mg/mL |
bcl-2(BCL2/782 + BCL2/796) Antibody |
BNC811023-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against bcl-2(BCL2/782 + BCL2/796), CF680R conjugate, Concentration: 0.1mg/mL |
BCL2 antibody (Ser87) |
70R-31342 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal BCL2 antibody (Ser87) |
BCL2 antibody (Ser70) |
70R-34633 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Purified Rabbit polyclonal BCL2 antibody (Ser70) |
BCL2 antibody (Thr56) |
70R-36053 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal BCL2 antibody (Thr56) |
BCL2 antibody (Ser70) |
70R-36846 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit Polyclonal BCL2 antibody (Ser70) |
BCL2 antibody (Thr56) |
70R-37145 |
Fitzgerald |
100 ug |
EUR 349 |
Description: Rabbit Polyclonal BCL2 antibody (Thr56) |
BCL2 antibody (Ser70) |
70R-37146 |
Fitzgerald |
100 ug |
EUR 349 |
Description: Rabbit Polyclonal BCL2 antibody (Ser70) |
BCL2 antibody (Thr69) |
70R-33372 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal BCL2 antibody (Thr69) |
BCL2 (pS70) Antibody |
20-abx009806 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
- Shipped within 5-10 working days.
|
BCL2 (pT69) Antibody |
20-abx009855 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
- Shipped within 5-10 working days.
|
BCL2 (pS87) Antibody |
20-abx121301 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
- Shipped within 5-10 working days.
|
Bcl2 (pS70) Antibody |
20-abx123324 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 217.00
-
EUR 356.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
- Shipped within 5-10 working days.
|
BCL2 (pT56) Antibody |
20-abx141042 |
Abbexa |
-
EUR 384.00
-
EUR 606.00
-
EUR 230.00
|
|
- Shipped within 5-10 working days.
|
BCL2 (pS70) Antibody |
20-abx141057 |
Abbexa |
-
EUR 384.00
-
EUR 606.00
-
EUR 230.00
|
|
- Shipped within 5-10 working days.
|
BCL2 Conjugated Antibody |
C38472 |
SAB |
100ul |
EUR 397 |
BCL2 (pS70) Antibody |
20-abx330227 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL2 (pS87) Antibody |
abx333406-100ul |
Abbexa |
100 ul |
EUR 467 |
- Shipped within 5-10 working days.
|
Bcl2 Polyclonal Antibody |
A52548 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: fast delivery possible |
BCL2 (pS70) Antibody |
20-abx000363 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
- Shipped within 5-10 working days.
|
BCL2 (pT56) Antibody |
20-abx000364 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
- Shipped within 5-10 working days.
|
anti- BCL2 antibody |
FNab00839 |
FN Test |
100µg |
EUR 505.25 |
- Recommended dilution: WB: 1:500 - 1:2000
- IHC: 1:50 - 1:100
- Immunogen: B-cell CLL/lymphoma 2
- Uniprot ID: P10415
- Gene ID: 596
- Research Area: Neuroscience, Cancer, Immunology, Cardiovascular
|
Description: Antibody raised against BCL2 |
anti- BCL2 antibody |
FNab00840 |
FN Test |
100µg |
EUR 505.25 |
- Recommended dilution: WB: 1:1000-1:10000
- IP: 1:500-1:5000
- IHC: 1:100-1:2000
- Immunogen: B-cell CLL/lymphoma 2
- Uniprot ID: P10415
- Gene ID: 596
- Research Area: Neuroscience, Cancer, Immunology, Cardiovascular
|
Description: Antibody raised against BCL2 |
Anti-BCL2 antibody |
STJ111127 |
St John's Laboratory |
100 µl |
EUR 393 |
Description: This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants. |
They additionally want so as to add worth to their lessons, assist college students to observe lectures, and make sure that the workload they offer their college students is acceptable.